Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Conversion Efficiency
Meditera Tibbi Malzeme Sanayi ve Ticaret AS cash flow conversion efficiency. Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a cash flow conversion efficiency ratio of 0.057x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL180.45 Million ≈ $4.04 Million USD) by net assets (TL3.17 Billion ≈ $71.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Cash flow conversion efficiency of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025. This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Meditera Tibbi Malzeme Sanayi ve Ticaret for real-time trading data and today's change.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Conversion Ratio Explained
Meditera Tibbi Malzeme Sanayi ve Ticaret AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS ranked by their cash flow conversion efficiency. Also see MEDTR stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Namhwa Industrial Co. Ltd
KQ:111710
|
0.025x |
|
Cemas Dokum Sanayi AS
IS:CEMAS
|
-0.024x |
|
Goa Carbon Limited
NSE:GOACARBON
|
-0.176x |
|
Marka Yatirim Holding AS
IS:MARKA
|
N/A |
|
Plan Optik AG
F:P4O
|
0.027x |
|
BIT Computer Co. Ltd
KQ:032850
|
0.031x |
|
SundayToz Corp
KQ:123420
|
0.013x |
|
IGLOO SECURITY Inc
KQ:067920
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
The table below shows the annual cash flow conversion efficiency of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025. Review Meditera Tibbi Malzeme Sanayi ve Ticaret free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | TL2.93 Billion ≈ $65.61 Million |
TL435.35 Million ≈ $9.75 Million |
0.149x | -44.31% |
| 2024-12-31 | TL2.93 Billion ≈ $65.52 Million |
TL780.69 Million ≈ $17.49 Million |
0.267x | -28.82% |
| 2023-12-31 | TL2.14 Billion ≈ $47.85 Million |
TL801.02 Million ≈ $17.94 Million |
0.375x | +6421.15% |
| 2022-12-31 | TL887.08 Million ≈ $19.87 Million |
TL5.10 Million ≈ $114.23K |
0.006x | -91.07% |
| 2021-12-31 | TL569.37 Million ≈ $12.75 Million |
TL36.64 Million ≈ $820.70K |
0.064x | -80.92% |
| 2020-12-31 | TL217.15 Million ≈ $4.86 Million |
TL73.26 Million ≈ $1.64 Million |
0.337x | +113.28% |
| 2019-12-31 | TL126.49 Million ≈ $2.83 Million |
TL20.01 Million ≈ $448.12K |
0.158x | -76.66% |
| 2018-12-31 | TL108.11 Million ≈ $2.42 Million |
TL73.26 Million ≈ $1.64 Million |
0.678x | -- |
About Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more